Senior M. Fresh from the biotech pipeline: fewer approvals, but biologics gain share. Nat Biotechnol. 2023. https://doi.org/10.1038/s41587-022-01630-6.
Article PubMed PubMed Central Google Scholar
Reichert JM. Antibodies to watch in 2017. Mabs-Austin. 2017;9(2):167–81. https://doi.org/10.1080/19420862.2016.1269580.
Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol. 2022;40(12):1722–60. https://doi.org/10.1038/s41587-022-01582-x.
Article CAS PubMed PubMed Central Google Scholar
Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies. 2020;9(3):ARTN 34. https://doi.org/10.3390/antib9030034.
Yasunaga M. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Semin Cancer Biol. 2020;64:1–12. https://doi.org/10.1016/j.semcancer.2019.06.001.
Article CAS PubMed Google Scholar
Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):ARTN 1. https://doi.org/10.1186/s12929-019-0592-z.
Walsh G. Post-translational modifications of protein biopharmaceuticals. Drug Discov Today. 2010;15(17–18):773–80. https://doi.org/10.1016/j.drudis.2010.06.009.
Article CAS PubMed Google Scholar
Gao XL, Rawal B, Wang Y, Li XW, Wylie D, Liu YH, et al. Targeted host cell protein quantification by LC-MRM enables biologics processing and product characterization. Anal Chem. 2020;92(1):1007–15. https://doi.org/10.1021/acs.analchem.9b03952.
Article CAS PubMed Google Scholar
Robinson CJ, Jones C. Quality control and analytical techniques for biopharmaceuticals. Bioanalysis. 2011;3(1):81–95. https://doi.org/10.4155/Bio.10.161.
Article CAS PubMed Google Scholar
Berkowitz SA, Engen JR, Mazzeo JR, Jones GB. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nat Rev Drug Discov. 2012;11(7):527–40. https://doi.org/10.1038/nrd3746.
Article CAS PubMed PubMed Central Google Scholar
Demmon S, Bhargava S, Ciolek D, Halley J, Jaya N, Joubert MK, et al. A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies. Biologicals. 2020;67:9–20. https://doi.org/10.1016/j.biologicals.2020.06.008.
Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771–83. https://doi.org/10.1208/s12248-014-9598-3.
Article CAS PubMed PubMed Central Google Scholar
Rathore AS, Winkle H. Quality by design for biopharmaceuticals. Nat Biotechnol. 2009;27(1):26–34. https://doi.org/10.1038/nbt0109-26.
Article CAS PubMed Google Scholar
Yu LX. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharm Res. 2008;25(4):781–91. https://doi.org/10.1007/s11095-007-9511-1.
Article CAS PubMed Google Scholar
Yang F, Zhang J, Buettner A, Vosika E, Sadek M, Hao ZQ, et al. Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control. Mabs-Austin. 2023;15(1):Artn 219766810. https://doi.org/10.1080/19420862.2023.2197668.
Zhao SS, Chen DDY. Applications of capillary electrophoresis in characterizing recombinant protein therapeutics. Electrophoresis. 2014;35(1):96–108. https://doi.org/10.1002/elps.201300372.
Article CAS PubMed Google Scholar
Valliere-Douglass J, Wallace A, Balland A. Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions. J Chromatogr A. 2008;1214(1–2):81–9. https://doi.org/10.1016/j.chroma.2008.10.078.
Article CAS PubMed Google Scholar
Sandra K, Vandenheede I, Sandra P. Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization. J Chromatogr A. 2014;1335:81–103. https://doi.org/10.1016/j.chroma.2013.11.057.
Article CAS PubMed Google Scholar
Du Y, Walsh A, Ehrick R, Xu W, May K, Liu HC. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. Mabs-Austin. 2012;4(5):578–85. https://doi.org/10.4161/mabs.21328.
Fekete S, Guillarme D, Sandra P, Sandra K. Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals. Anal Chem. 2016;88(1):480–507. https://doi.org/10.1021/acs.analchem.5b04561.
Article CAS PubMed Google Scholar
Wang Y, Li XJ, Liu YH, Richardson D, Li HJ, Shameem M, Yang XY. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion. Mabs-Austin. 2016;8(8):1477–86. https://doi.org/10.1080/19420862.2016.1226715.
Rogstad S, Faustino A, Ruth A, Keire D, Boyne M, Park J. A Retrospective evaluation of the use of mass spectrometry in FDA biologics license applications. J Am Soc Mass Spectr. 2017;28(5):786–94. https://doi.org/10.1007/s13361-016-1531-9.
Li XW. Recent applications of quantitative mass spectrometry in biopharmaceutical process development and manufacturing. J Pharmaceut Biomed. 2023;234:ARTN 115581. https://doi.org/10.1016/j.jpba.2023.115581.
Jiang TT, Edwards N, Sukumar N, Mayers M, Higgins J, Kosanam H. Development and validation of LC-MS/MS method for quantification of protease inhibitor Pepstatin A to monitor its robust clearance in vaccine downstream process. J Chromatogr B. 2023;1215:ARTN 123589. https://doi.org/10.1016/j.jchromb.2022.123589.
Rogers RS, Nightlinger NS, Livingston B, Campbell P, Bailey R, Balland A. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics. Mabs-Austin. 2015;7(5):881–90. https://doi.org/10.1080/19420862.2015.1069454.
Ren D. Advancing Mass Spectrometry Technology in cGMP Environments. Trends Biotechnol. 2020;38(10):1051–3. https://doi.org/10.1016/j.tibtech.2020.06.007.
Article CAS PubMed Google Scholar
Rogers RS, Abernathy M, Richardson DD, Rouse JC, Sperry JB, Swann P, et al. A view on the importance of “Multi-Attribute Method” for measuring purity of biopharmaceuticals and improving overall control strategy. AAPS J. 2018;20(1):ARTN 7. https://doi.org/10.1208/s12248-017-0168-3.
Li XW, Pierson NA, Hua XQ, Patel BA, Olma MH, Strulson CA, et al. Analytical performance evaluation of identity, quality-attribute monitoring and new peak detection in a platform multi-attribute method using Lys-C digestion for characterization and quality control of therapeutic monoclonal antibodies. J Pharm Sci-Us. 2023;112(3):691–9. https://doi.org/10.1016/j.xphs.2022.10.018.
Liu Y, Fernandez J, Pu Z, Zhang H, Cao L, Aguilar I, et al. Simultaneous monitoring and comparison of multiple product quality attributes for cell culture processes at different scales using a LC/MS/MS based multi-attribute method. J Pharm Sci-Us. 2020;109(11):3319–29. https://doi.org/10.1016/j.xphs.2020.07.029.
Hines AR, Edgeworth M, Devine PWA, Shepherd S, Chatterton N, Turner C, et al. Multi-attribute monitoring method for process development of engineered antibody for site-specific conjugation. J Am Soc Mass Spectr. 2023;34(7):1330–41.
Comments (0)